Guardant Health
GH
#1679
Rank
NZ$21.50 B
Marketcap
NZ$163.98
Share price
2.94%
Change (1 day)
121.14%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): NZ-$5.67

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.78. In 2024 the company made an earnings per share (EPS) of NZ-$6.22 an increase over its 2023 EPS that were of NZ-$7.48.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$5.67-8.79%
2024NZ-$6.22-16.82%
2023NZ-$7.48-33.13%
2022NZ-$11.1860%
2021NZ-$6.9955.04%
2020NZ-$4.51207.14%
2019NZ-$1.47-19.81%
2018NZ-$1.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$4.85-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$3.74-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA